Figure 1 (Image 01)
Prismasol Injection
Product Images NDC 24571-108
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Prismasol (NDC 24571-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vantive Us Healthcare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Image 02)
Figure 3 (Image 03)
Figure 4 (Image 04)
This text is describing a product called "Luer Connector", but there is not enough information available to provide a more detailed description.*
Image 05
This appears to be a set of mixing steps and information about a medical solution called PrismaSel BGK0/2.5+. The solution is marked with an NDC# 24571-108-08 and is a replacement solution for Continuous Renal Replacement Therapy. The text also lists the contents of the solution before reconstruction, including calcium, magnesium, and glucose. The solution should be stored at a temperature between +20°C to +25°C. The rest of the text contains various characters and letters that do not form coherent English sentences.*
Figure 7 (Image 06)
Figure 7 (Image 07)
This appears to be a set of mixed instructions, measurements, and product details. There is a product code, NDC# 24571-103-08, for PrismaSel BGK2/3.5 +, which appears to be a replacement solution for Continuous Renal Replacement Therapy. The text includes mixing steps, but it is not clear what these steps are for, as the instructions appear to be incomplete. Overall, there is no useful description to generate from this text.*
Figure 8 (Image 08)
The text appears to contain a set of mixing steps to prepare a solution (probably for Continuous Renal Replacement Therapy). The steps involve breaking seal from top corners and fully opening the bag. The rest of the text includes a list of components such as magnesium, sodium, potassium, and dextrose. It also includes temperature and storage instructions as well as cautions on exposure to heat and endotoxins. The text seems to lack coherence and organization, and appears to contain errors and incomplete sentences.*
Image 09
Mixing Steps are provided in the text. To break the seal top corners should be squeezed and to fully open the seal, bag sides are to be squeezed. Further, the information on the product NDC# 24571-111-06 and the theoretical osmolarity is provided. The text also indicates the composition of the solution in terms of different chemical compounds like sodium chloride, lactate, bicarbonate, and potassium which are present in the solution along with their weight. This solution is meant for medical use only and requires proper handling, such as the removal of some compartments, before use. If the solution is not used, it should be discarded before treating a patient. The information in the text is not comprehensive and lacks context.*
Prismasol Representative Container Label Bgk0/2.5 1 Of 2 (Image 10)
This text appears to be a set of instructions for mixing a solution for Continuous Renal Replacement Therapy. The text provides details on opening the solution bag and adding various components to prepare the solution. It also includes information on how to handle, store, and discard the solution. There is a barcode number, product ID, and company name mentioned towards the end of the text.*
Prismasol Representative Container Label Bgk0/2.5 2 Of 2 (Image 11)
The provided text appears to be a set of mixing instructions and a medical product label for a solution used in continuous renal replacement therapy. The instructions include squeezing the bag sides to open the seal, breaking the seal on the top corners, and using the NDC code 24571-114-04. The product is called PrismaSel BGK4/0/1.2+ and is labeled for prescription use only. However, some of the text is missing or illegible, and the mixture requires reconstitution before use. Overall, the information provided is limited and fragmented, so it may not be entirely useful without the complete source document.*
Prismasol Representative Carton Label Bgk0/2.5 (Image 12)
This is a package description of a medical product used for Continuous Renal Replacement Therapy. The product is a replacement solution and requires controlled conditions for storage. The package has two compartments - one labeled A and the other B. The package contains a mixture of different chemicals like Phosphate, Magnesium Chloride, and Sodium Carbonate. There is a dosage instruction provided on the package, which must be followed carefully. The package is not made with natural rubber latex. The product is manufactured by Baer Healthcare Corporation and is called GAMBRO EIE.*
Prismasol Representative Container Label Bgk4/2.5 1 Of 2 (Image 13)
This text appears to be a set of instructions for using a solution called "Phoxillum B22K4/0" for continuous renal replacement therapy. The text includes information about the solution's composition, mixing steps, dosing instructions, and storage requirements. There is also a reference to a product called "OGAMBRO".*
Prismasol Representative Container Label Bgk4/2.5 2 Of 2 (Image 14)
The text seems to be a combination of different phrases, codes and symbols without a clear meaning or purpose. Therefore, the description is not available.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
